Jelovac, Ana
McCaffrey, Cathal
Terao, Masashi
Shanahan, Enda
Mohamed, Enas
Whooley, Emma
McDonagh, Kelly
McDonogh, Sarah
Igoe, Anna
Loughran, Orlaith
Shackleton, Ellie
O’Neill, Ciaran
McLoughlin, Declan M.
Funding for this research was provided by:
Health Research Board (DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013, DIFA-2018-013)
Article History
Received: 5 November 2023
Accepted: 8 November 2023
First Online: 16 November 2023
Declarations
:
: The study received ethical approval from the Mater Misericordiae Institutional Review Board (Protocol No. 1/478/97) and St Patrick’s Mental Health Services Research Ethics Committee (Protocol No. 05/20). Latest protocol amendment (Version 6.1 20/Oct/2023) was approved by the National Research Ethics Committee on 01 November 2023.
: Not applicable. This manuscript does not contain any data.
: DMM has received speaker’s honoraria from Mecta, Otsuka and Janssen, and an honorarium from Janssen for participating in an esketamine advisory board meeting. OL is currently an employee of COMPASS Pathways. The contributions made by OL to this manuscript are associated with her former employment at Trinity College Dublin and are not associated with COMPASS Pathways. Other authors declare no competing interests.